These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 28498184)
1. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study. Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S; J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184 [TBL] [Abstract][Full Text] [Related]
2. Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi). Phiri S; Tweya H; van Lettow M; Rosenberg NE; Trapence C; Kapito-Tembo A; Kaunda-Khangamwa B; Kasende F; Kayoyo V; Cataldo F; Stanley C; Gugsa S; Sampathkumar V; Schouten E; Chiwaula L; Eliya M; Chimbwandira F; Hosseinipour MC; J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S140-S148. PubMed ID: 28498183 [TBL] [Abstract][Full Text] [Related]
3. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study. Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz. Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC; Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233 [TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi. van Lettow M; Tweya H; Rosenberg NE; Trapence C; Kayoyo V; Kasende F; Kaunda B; Hosseinipour MC; Eliya M; Cataldo F; Gugsa S; Phiri S; Reprod Health; 2017 Jul; 14(1):82. PubMed ID: 28693525 [TBL] [Abstract][Full Text] [Related]
6. Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study. Herce ME; Chagomerana MB; Zalla LC; Carbone NB; Chi BH; Eliya MT; Phiri S; Topp SM; Kim MH; Wroe EB; Chilangwa C; Chinkonde J; Mofolo IA; Hosseinipour MC; Edwards JK PLoS Med; 2021 Sep; 18(9):e1003780. PubMed ID: 34534213 [TBL] [Abstract][Full Text] [Related]
7. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(8):148-51. PubMed ID: 23446514 [TBL] [Abstract][Full Text] [Related]
8. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe. Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
10. Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial. Joseph J; Gotora T; Erlwanger AS; Mushavi A; Zizhou S; Masuka N; Boeke CE; Mangwiro AZ J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S190-S197. PubMed ID: 28498189 [TBL] [Abstract][Full Text] [Related]
11. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study. Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984 [TBL] [Abstract][Full Text] [Related]
12. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme. Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524 [TBL] [Abstract][Full Text] [Related]
13. Timing of HIV testing among pregnant and breastfeeding women and risk of mother-to-child HIV transmission in Malawi: a sampling-based cohort study. Chagomerana MB; Edwards JK; Zalla LC; Carbone NB; Banda GT; Mofolo IA; Hosseinipour MC; Herce ME J Int AIDS Soc; 2021 Mar; 24(3):e25687. PubMed ID: 33749155 [TBL] [Abstract][Full Text] [Related]
14. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program. Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi. Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Harrington BJ; DiPrete B; Wallie S; Jumbe A; Limarzi L; Hosseinipour MC PLoS One; 2018; 13(12):e0209052. PubMed ID: 30543685 [TBL] [Abstract][Full Text] [Related]
16. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program. Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920 [TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi. Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775 [TBL] [Abstract][Full Text] [Related]
18. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme. Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186 [TBL] [Abstract][Full Text] [Related]
19. Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi). Rosenberg NE; van Lettow M; Tweya H; Kapito-Tembo A; Bourdon CM; Cataldo F; Chiwaula L; Sampathkumar V; Trapence C; Kayoyo V; Kasende F; Kaunda B; Speight C; Schouten E; Eliya M; Hosseinipour M; Phiri S; J Acquir Immune Defic Syndr; 2014 Nov; 67 Suppl 2(0 2):S114-9. PubMed ID: 25310116 [TBL] [Abstract][Full Text] [Related]
20. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi. Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]